October 2022 Vol 7 – Monitor and Identify MRD in a B-ALL Patient
June 2022 Vol 6 – Measurable Residual Disease Pediatric Case Study
January 2022 Vol 5 – Flow cytometric findings reveal an aberrant myeloid progenitor population present at 0.1%
September 2021 Vol 4 – Depicting how true technology integration renders an accurate diagnosis in a difficult case
June 2021 Vol 3 – Flow Cytometry Identifies Secondary Underlying Neoplastic Population
January 2021 Vol 2 – Leader in the detection of Myelodysplasia (MDS)
August 2020 Vol 1 – Suspected MRD without Diagnostic Sample
